Okay, let's tackle this question about SDH-deficient GIST. The user provided the question and correct answer but didn't fill in the options. Hmm, that's a bit tricky. Maybe I can infer the options based on common knowledge about SDH-deficient GIST.

First, I need to recall what SDH-deficient GIST is. Succinate dehydrogenase (SDH) is part of the electron transport chain and the Krebs cycle. Deficiency in SDH leads to the accumulation of succinate, which acts as an oncometabolite, causing hypoxia-inducible factor (HIF) activation. This is different from the more common KIT/PDGFRA-mutant GISTs.

Now, the question is asking which statement is NOT true about SDH-deficient GIST. The correct answer was given, but the options aren't listed. Let me think of typical characteristics of SDH-deficient GIST. They are usually seen in children and young adults, often have a better prognosis compared to wild-type GISTs, and are associated with Carney triad. They are also more likely to occur in the stomach and have a specific immunohistochemical profile, like being negative for KIT (CD117) and DOG1.

Common misconceptions or incorrect statements might include things like being CD117 positive (which is actually incorrect), having a worse prognosis, or not being associated with Carney triad. So if the options included something about CD117 positivity, that would be the exception. Alternatively, maybe a statement about being more aggressive or having a higher mitotic rate would be incorrect.

Since the correct answer is supposed to be the exception, I need to figure out which of these points is false. Let me structure the explanation accordingly. The core concept is the pathogenesis and clinical features of SDH-deficient GIST. The correct answer would be the one that contradicts known facts about these tumors. For example, if an option states that SDH-deficient GISTs are CD117 positive, that's incorrect because they are typically negative for CD117.

I should also consider the clinical pearl. A high-yield fact is that SDH-deficient GISTs are part of the Carney triad and are often CD117 negative, which differentiates them from other GISTs. So if one of the options claims CD117 positivity, that's the exception. Therefore, the correct answer would be the option stating that SDH-deficient GISTs are CD117 positive.

**Core Concept**
SDH-deficient gastrointestinal stromal tumors (GISTs) are a distinct subgroup driven by mutations in the succinate dehydrogenase complex (SDHB, SDHC, SDHD). They are characterized by succinate accumulation, HIF-1α activation, and unique clinicopathologic features, including association with Carney triad and CD117 (KIT) negativity.

**Why the Correct Answer is Right**
SDH-deficient GISTs are typically CD117 (KIT) negative, distinguishing them from KIT/PDGFRA-mutant GISTs. They occur in younger patients, are often gastric, and are part of Carney triad (GIST, paraganglioma, pulmonary chondroma).

✓ Correct Answer: B. Negative for DOG-1